Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Nussbaumer-Ochsner, T. Latshang, S. Ulrich, M. Kohler, R. Thurnheer, K. E. Bloch (Zurich, Muensterlingen-Scherzingen, Switzerland). Acetazolamide improves central sleep apnea in patients with obstructive sleep apnea syndrome at altitude. Eur Respir J 2009; 34: Suppl. 53, 3730

Member's Comments

No comment yet.

Related content which might interest you: Vasoconstriction during the night in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 419s Year: 2006 Prevalance of daytime hypercapnia in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 574s Year: 2002 Metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2007 - Sleep apnoea Year: 2007 Daytime hypercapnia in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 493s Year: 2002 Nocturnal intermitent hypoxemia in patients with pulmonary hypertension and sleep apnea hypopnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 657s Year: 2006 Prevalence of complex sleep apnea among German patients with obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 The influence of obesity in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 295s Year: 2002 Enuresis in obstructive sleep apnea syndrome patients Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012 Autonomic changes during obstructive and central apneas in patients with sleep apnea syndrome Source: Eur Respir J 2001; 18: Suppl. 33, 333s Year: 2001 The factors related to the daytime hypercapnia in obstructive sleep apnea syndrome Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009 Pulmonary hypertension and obstructive sleep apnea syndrome -Marmara Universitypediatric sleep laboratory experience Source: Virtual Congress 2020 – Respiratory physiology and sleep: what is new? Year: 2020 Pathophysiological consequences of obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Hypertension and obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Predictors of long-term PAP-adherence in obstructive sleep apnea syndrome Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Oxygen for the treatment of obstructive sleep apnoea hypopnoea syndrome Source: Breathe, 15 (3) e104; 10.1183/20734735.0206-2019 Year: 2019 Day time pulmonary hypertension in patients with obstructive sleep apnea hypopnea syndrome Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Combined autoCPAP and acetazolamide treatment controls breathing disturbances in patients with obstructive sleep apnea syndrome at altitude Source: Annual Congress 2010 - Sleep apnoea: insights from basic and clinical research Year: 2010 Mixed apnea metrics during diagnostic polysomnographies in obstructive sleep apnea patients with/without treatment-emergent central sleep apnea Source: International Congress 2019 – Diagnostic issues in obstructive sleep apnoea Year: 2019 Correlation between intermittent nocturnal hypercapnia and depressive symptoms in patients with obstructive sleep apnea syndrome Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011 The velumount device for obstructive sleep apnoea Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009